Segregating reading room tasks into “image interpretative” and “non-image interpretive” workflows improved radiologists’ perception of disruptions and mental effort while increasing workplace satisfaction, according to a study published in Academic Radiology. 

Researchers from Memorial Sloan Kettering Cancer Center believe that imaging biomarkers will play an increasingly large role in oncology through the philosophy of precision medicine, especially in the case of heterogeneous tumors. Data derived from imaging may enable clinicians to distinguish between benign and cancerous tissue and predict treatment response, but certain challenges must be addressed first, according to Evis Sala, MD, PhD, et al.

As radiology groups prepare for value-driven medicine, growth continues to be a strategy

The highly fragmented sector of radiology practice is experimenting with confederation models to remain competitive with national radiology services providers

Journalism, public relations, and marketing: Today’s specialists are expected to do it all

For women with early-stage breast cancer, deciding whether or not to undergo expensive molecular imaging tests can be a difficult decision. While the tests can assess risk of recurrence, they may not be necessary at all—prompting scientists at the Johns Hopkins Kimmel Cancer Center to create a web app that can aid in patients' decision-making. 

While combination PET/CT imaging is one of the best ways to detect lung cancer, there is concern about patient dose when using the modality on a large scale. However, researchers from Singapore optimized a low-dose PET scan while maintaining reliable cancer detection, according to a study published in the Journal of Nuclear Medicine. 

As the second most common cancer in women and the third in men, colorectal cancer starts on the left side of the colon roughly 80 percent of the time. Clinical trails conducted by Amgen found that using Vectibix (panitumumab) in patients with metastatic colorectal cancer improved overall survival rates.